Citigroup, TD Cowen, Lazard Asset Management LLC, and Leerink Partners have issued positive analyst ratings and price target increases for GoodRx.
2 reports, 1 independent
Updated Aug 18
Gone quiet
- Reports
- 2
- Developments
- 2
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Citigroup, TD Cowen, Lazard Asset Management LLC, and Leerink Partners have issued positive analyst ratings and price target increases for GoodRx.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- TD Cowen raised price targets for GoodRx stock.Sub-event
Analysts including Citigroup, TD Cowen, Lazard, and Leerink Partners have raised price targets for GoodRx.1 source
Keep exploring
The entities involved
-
GoodRx
American prescription drug price tracking website and app
Nothing else this week.